We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Optical Methodology for Detection of COVID-19 Beats RT-PCR in Speed and Sample Size

By LabMedica International staff writers
Posted on 21 Feb 2022

An optical methodology for the rapid detection of COVID-19 provides an advantage over PCR in terms of the speed of sample processing and the ability to simultaneously analyze a large number of samples.

The new methodology developed by researchers at the University of Seville (Seville, Spain) has obtained a sensitivity of 100% and a specificity of 87.5% in the detection of SARS-CoV-2 in nasopharyngeal exudate (the same samples used in a PCR test) from symptomatic people. It has also been possible to detect the presence of SARS-CoV-2 in fresh saliva of asymptomatic people, as well as to detect, differentiate and quantify two types of synthetic viruses (lentiviruses and synthetic coronaviruses) in two biofluids (saline solution and artificial saliva).


Image: Researchers working on the project (Photo courtesy of University of Seville)
Image: Researchers working on the project (Photo courtesy of University of Seville)

The new methodology allows for the detection of viruses in liquid droplets and dry residues deposited on surfaces, through hyperspectral imaging and data processing based on advanced statistics and artificial intelligence. It allows rapid processing of multiple samples simultaneously, without contact or reagents and with relatively simple equipment, usable by personnel with minimal training. The new technique uses standard optical equipment and has been developed so that it can be implemented in resource-constrained settings.

However, the researchers have warned that these results should still be viewed with caution, as they constitute a 'proof of concept', with relatively small numbers of cases, under partially controlled laboratory conditions. For this reason, they are currently working on validating this new methodology under generic conditions, including new variants of the virus and the effects of vaccines.

Related Links:
University of Seville 


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test

Latest COVID-19 News

New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
21 Feb 2022  |   COVID-19

Long COVID Etiologies Found in Acute Infection Blood Samples
21 Feb 2022  |   COVID-19

Novel Device Detects COVID-19 Antibodies in Five Minutes
21 Feb 2022  |   COVID-19